1. Epigenetic Inactivation of TRAIL Decoy Receptors at 8p12-21.3 Commonly Deleted Region Confers Sensitivity to Apo2L/TRAIL-Cisplatin Combination Therapy in Cervical Cancer Narayan, Gopeshwar; Xie, Dongxu; Ishdorj, Ganchimeg; Scotto, Luigi; Mansukhani, Mahesh M.; Pothuri, Bhavana; Wright, Jason D.; Kaufmann, Andreas; Schneider, Achim; Arias-Pulido, Hugo; Vundavalli, Murty V. 2016 Articles EpigeneticsGeneticsCervix uteri--CancerCervix uteri--Cancer--TreatmentCarcinogenesis
2. Protocadherin PCDH10, Involved in Tumor Progression, Is a Frequent and Early Target of Promoter Hypermethylation in Cervical Cancer Narayan, Gopeshwar; Scotto, Luigi; Neelakantan, Vijayalakshmi; Kottoor, Sherine H.; Wong, Ada Ho Yan; Loke, Shee‐Loong; Mansukhani, Mahesh M.; Pothuri, Bhavana; Wright, Jason D.; Kaufmann, Andreas; Schneider, Achim; Arias-Pulido, Hugo; Tao, Qian; Vundavalli, Murty V. 2009 Articles GeneticsCervix uteri--CancerCervix uteri--Cancer--TreatmentPromoters (Genetics)Methylation
3. Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha Scotto, Luigi; Narayan, Gopeshwar; Nandula, Subhadra; Subramaniyam, Shivakumar; Kaufmann, Andreas; Wright, Jason D.; Pothuri, Bhavana; Mansukhani, Mahesh M.; Schneider, Achim; Arias-Pulido, Hugo; Murty, Vundavalli V. 2008 Articles ChromosomesCervix uteri--CancerMolecular biologyGenetics
4. Gene Dosage Alterations Revealed by cDNA Microarray Analysis in Cervical Cancer: Identification of Candidate Amplified and Overexpressed Genes Narayan, Gopeshwar; Bourdon, Veronique; Chaganti, Seeta; Arias-Pulido, Hugo; Nandula, Subhadra; Rao, Pulivarthi; Gissmann, Lutz; Dürst, Matthias; Schneider, Achim; Pothuri, Bhavana; Mansukhani, Mahesh M.; Basso, Katia; Chaganti, R.S.K.; Vundavalli, Murty V. 2007 Articles GeneticsGenomicsCervix uteri--CancerOverexpression (Genetics)Gene amplification